Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Director departure
Inv. presentation

CytoDyn Inc. (CYDY) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/25/2022 8-K/A Quarterly results
06/02/2020 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "8-K/A"
08/31/2018 8-K/A Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
08/19/2015 8-K/A Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "License Agreement between CytoDyn Inc. and Lonza Sales AG"
12/06/2013 8-K/A Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
11/02/2006 8-K/A Changes in Registrant's Certifying Accountant
10/24/2006 8-K/A Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Financial State...
Docs: "Consent of auditors Pender Newkirk & Company, LLP"
10/02/2006 8-K/A Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhi...
Docs: "RELEASE ISSUED JULY 19, 2006",
"Audited Financial Statements of Subsidiary for the period ended July 17, 2006",
"Unaudited Pro forma financial information for CytoDyn, Inc. and Subsidiary as of July 17, 2006",
"Audited Financial Statements for CytoDyn, Inc. for the period October 28, 2003 (inception) through May 31, 2006"
09/26/2006 8-K/A Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Docs: "Securities and Exchange Commission 450 Fifth Street, NW Washington, D.C. 20549"
09/01/2006 8-K/A Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Docs: "Securities and Exchange Commission 450 Fifth Street, NW Washington, D.C. 20549"
01/06/2006 8-K/A Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Financial Representative Agreement with J.P. Turner & Company, LLC"
01/12/2004 8-K/A Changes in control of registrant, Acquisition or disposition of assets, Financial statements and exhibits
Docs: "CYTODYN, INC. EXHIBIT INDEX",
"Acquisition Agreement dated Filed electronically September 30, 2003, and with this Form Amendment Number 1 to the Acquisition Agreement Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. CytoDyn, Inc. Date: January 12, 2004 By: /s/ Allen D. Allen Allen D. Allen, President, Chief Executive Officer"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy